LEMBOREXANT vs LENVATINIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
LEMBOREXANT vs LENVATINIB: Safety Overview
| Metric | LEMBOREXANT | LENVATINIB |
|---|---|---|
| Total FAERS Reports | 989 | 33,766 |
| Deaths Reported | 44 | 4,449 |
| Death Rate | 4.4% | 13.2% |
| Hospitalizations | 278 | 19,975 |
| Average Patient Age | 58.9 yrs | 65.4 yrs |
| % Female Patients | 63.4% | 55.8% |
| FDA Approval Date | Apr 7, 2020 | Feb 13, 2015 |
| Manufacturer | Eisai Inc. | Eisai Inc. |
| Route | ORAL | ORAL |
| Marketing Status | Prescription | Prescription |